© All rights reserved to Barnea Jaffa Lande Law offices

Search by Practice

Latest Updates /  Mergers and Acquisitions

May 23, 2021

Representing Migdal in Investment in Fintech Company Sunbit

The fintech company Sunbit, which has developed an AI-based technology that enables personalized payment options, raised USD 130 million in a series D financing round led by Group 11, Zeev Ventures, and Migdal Insurance. Our firm's Micky Barnea and Ariella Dreyfuss represented Migdal in the transaction.

April 13, 2021

Barnea Represented Gnrgy in Sale to O.P.C. Energy

Firm partner Yuval Lazi and associate Mayer Winkler advised Gnrgy, a company operating in the field of electric vehicle charging, in its sale to public company O.P.C. Energy, part of the Idan Ofer Group. The transaction amount was NIS 67 million. Our legal services consisted of advising on all aspects of the transaction, including antitrust issues.

April 8, 2021

TipRanks Completes USD 77 Million Funding Round

Israel-based fintech company TipRanks announced today the completion of a USD 77 million funding round led by Prytek and Mor Investment House. Adv. Ariella Dreyfuss represented TipRanks in the round. TipRanks currently has 60 employees located mostly in Tel Aviv. With the new investment, the company plans to double its workforce and open offices in New York.

January 21, 2021

Dentsply Sirona Acquires Datum Dentel Ltd.

We represented Datum BioTech Ltd and its non-wholly owned subsidiary, Datum Dental Ltd, an Israeli company that develops medical devices for the mouth and jaw, in its sale to American company Dentsply Sirona. Advs. Micky Barnea and Ariella Dreyfuss advised the client throughout the deal.

November 17, 2020

Representing Menora Mivtachim in USD 30 Million Investment in Jio

Jio, India's largest telecommunications company, recently completed a major investment round, raising money from leading multinational corporations like Google and Facebook. Israeli insurance company Menora Mivtachim also invested about USD 30 million as part of the round. Firm partner Roy Engel accompanied Menora Mivtachim in the investment.

November 15, 2020

ISA: Expanding Disclosure on Independent Committees

The Israel Securities Authority will soon require public companies to disclose details about independent committees tasked with overseeing transactions with controlling shareholders. The staff position was put together due to the increased need for supervision and oversight of decision-making processes in transactions between public companies and their controlling shareholders.

November 1, 2020

Representing Danel in Acquisition of Manor Medical

Our firm represented Danel in the acquisition of 51% of Manor Medical, an egg donation and surrogacy company. Advs. Micky Barnea, and Ilan Blumenfeld represented Danel in the acquisition with a value of up to NIS 140 million.

June 22, 2020

Barnea Represented Cyberx Shareholder in Microsoft Acquisition

We represented Inven Capital, a Czech-based VC fund and a shareholder in Cyberx Israel, an Israeli IoT ICS cybersecurity startup, in Cyberx's sale to Microsoft for USD 165 million. CyberX has gained tremendous customer growth, with a number of leading companies using its IoT security platform to protect their web facilities. Cyberx has raised about USD 48 million since its inception in 2013. This is Microsoft’s eighth acquisition in Israel in the last decade.

July 18, 2019

Barnea Representing Azrieli Group in Equity Investment in Compass Datacenters LLC.

Our firm is representing Azrieli Group in its equity investment in Compass Datacenters LLC., a company engaged in the commercialization of hyperscale data centers in North America. This acquisition is part of Azrieli Group's overall expansion into real estate in the international arena.  

June 18, 2019

Barnea Represented Axcel in the Acquisition of Phase One

Our firm represented Axcel in the acquisition of Phase One from Silverfleet Capital. Axcel is a leading Nordic private equity firm focusing on mid-market companies. It has a broad base of both Nordic and international investors.

March 20, 2019

Barnea Represented Danel Ltd. in the Acquisition of Levinger Group

Our firm represented Danel Ltd. in a deal to acquire 51% of Levinger Group. This marks a strategic move by Danel to expand into the private health field.

December 4, 2018

US Court Allows Company to Cancel a Transaction Based on “Material Adverse Effect” Clause in Agreement

The Delaware Court of Chancery issued a precedent recently, whereby an acquisition agreement may be cancelled due to the occurrence of a “Material Adverse Effect” (MAE) in the acquired entity.

November 20, 2018

Barnea represented Senetas Corporation Ltd.

Our firm represented Senetas Corporation in a USD 8 million investment in the Israeli cyber company Votiro Cybersec Global Limited

November 8, 2018

Barnea Represented Sakal Global Duty Free Ltd.

Our firm represented the owner of Sakal Global Duty Free Ltd. in the sale of the company as part of the sale of the entire Sakal Group to businessman Teddy Sagi.

May 14, 2018

Ethemba Capital Selling Control in Avgol to Indorama Ventures

Our firm is representing British private equity firm Ethemba Capital in its sale of control in Israeli company Avgol Nonwoven Industries Ltd. to Indorama Ventures Spain S.L., a chemical manufacturer whose shares are traded on the Thai stock exchange. The price of the sale is valued at NIS 1.7 billion.

May 9, 2018

Barnea Represented ADM Capital in Investment in Israeli Startup Rootility

Barnea represented ADM Capital, a UK-based investment fund, in an investment round in the Israeli plant-breeding startup Rootility.

May 7, 2018

IFF to Buy Israel's Frutarom

Our firm represented International Flavors Fragrances Inc. (IFF) in its acquisition of Frutarom, the Israeli flavors and ingredients maker, for USD 7.1 billion.

April 18, 2018

Barnea Represented Greenyard Fresh in Acquisition of Mor International

Our firm represented Greenyard Fresh, a global market leader of fresh, frozen, and prepared fruits and vegetables, in the acquisition of 49% of Mor International.

March 27, 2018

Barnea Represented Cellebrite in the Sale of the Mobilogy Division to a US Fund

Our firm represented Cellebrite in the sale of the Mobilogy Division to the American ESW Capital Fund. The Mobilogy division, which operates as a separate brand, offers technological solutions for operators, retailers and aftermarket  that enhance the customer experience in-store beyond.

February 1, 2018

Barnea Advised on the $703 Million Acquisition of Theramex by CVC

Barnea Advised on the $703 Million Acquisition of Theramex by CVC Capital Partners. Theramex is Teva Pharmaceutical Industries' global women’s health portfolio.